Skip to main content

Table 2

From: Tumor mica status predicts the efficacy of immunotherapy with cytokine-induced killer cells for patients with gastric cancer

Characteristics

 

Total95

MICA highN=38

MICA lowN=57

p-value

Sex

Male

66

25

41

0.524

 

Female

29

13

16

 

Age

<65

67

21

46

0.008

 

≥65

28

17

11

 

Histological grade

G1-G2

48

23

25

0.111

 

G3-G4

47

15

32

 

Stage

II

44

23

21

0.023

 

III

51

15

36

 

Adjuvant Chemotherapy

Xelox, Folfox4

57

25

32

0.347

 

PF

38

13

25

 

CIK cycles

<5

54

18

36

0.128

 

≥5

41

20

21

Â